Cargando…
Upstream solutions for price-gouging on critical generic medicines
Exorbitant price increases for critical off-patent medicines have received considerable media attention in recent months, leading to an investigation by the U.S. Senate. However, much of this attention has focused upon the companies that initiated the price increases, all of whom had recently acquir...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2016
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4852412/ https://www.ncbi.nlm.nih.gov/pubmed/27141308 http://dx.doi.org/10.1186/s40545-016-0064-8 |